Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer-Reference-Cited by-同舟云学术

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer

Published:2014-03-20 Issue:8 Volume:135 Page:1961-1969
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hu Xichun¹,Zhang Jian¹,Xu Binghe²,Jiang Zefei³,Ragaz Joseph⁴,Tong Zhongsheng⁵,Zhang Qingyuan⁶,Wang Xiaojia⁷,Feng Jifeng⁸,Pang Danmei⁹,Fan Minhao¹,Li Jin¹,Wang Biyun¹,Wang Zhonghua¹,Zhang Qunling¹,Sun Si¹,Liao Chunmei¹

Affiliation:

1. Department of Medical Oncology; Fudan University, Shanghai Cancer Center, China; Department of Oncology; Shanghai Medical College, Fudan University; Shanghai China

2. Cancer Hospital, Chinese Academy of Medical Sciences; Beijing China

3. Department of Breast Cancer; Affiliated Hospital of Academy of Military Medical Sciences; Beijing China

4. School of Population and Public Health; University of British Columbia; Vancouver BC Canada

5. Tianjin Medical University Cancer Institute and Hospital; Tianjin China

6. Harbin Medical University Cancer Hospital; Harbin China

7. Zhejiang Cancer Hospital; Hangzhou China

8. Department of Medical Oncology; Nanjing Medical University affiliated Cancer Hospital; Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research; Nanjing China

9. Foshan No. 1 People's Hospital; Foshan China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. Chemotherapy for metastatic breast cancer;Mayer;Hematol Oncol Clin North Am,2007

2. Molecular stratification of triple-negative breast cancers;Perou;Oncologist,2011

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci USA,2001

4. T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy;Kaplan;Breast J,2009

5. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci USA,2003

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymoquinone Enhances the Antitumor Activity of Apatinib Against Gastrointestinal Tumors Through the STAT3 Pathway;2024-08-01

2. Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action;International Journal of Molecular Sciences;2024-06-06

3. Efficacy and safety of tyrosine kinase inhibitors for advanced metastatic thyroid cancer: A systematic review and network meta-analysis of randomized controlled trials;Medicine;2024-04-12

4. The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer;Cancer Medicine;2024-04

5. The Efficiency and Toxicity Of Anlotinib in Combination With Docetaxel Followed by Epirubicin and Cyclophosphamide Regimen as Neoadjuvant Treatment in IIB to IIIA Triple Negative Breast Cancer: A Single-Arm, Multicenter, Open-Label, Phase II Study;Clinical Breast Cancer;2024-03